Lessons Learned from Phagocytic Function Studies in a Large Cohort of Patients with Recurrent Infections
Tóm tắt
There is a paucity of data on the relationship between demographic characteristics, specific clinical manifestations, and neutrophil dysfunction, guiding physicians to decide which clinical signs and symptoms are a code for an underlying phagocytic disorder. The data over a 21-year period of all adult and pediatric patients referred to our Laboratory for Leukocyte Functions with recurrent pyogenic infections were analyzed. Neutrophil function studies included chemotaxis, superoxide production (SOP), bactericidal activity (BA), and specific studies in case of suspected primary phagocytic disorder (PPD). Neutrophil dysfunction was found in 33.6% of 998 patients; chemotaxis in 16.6%, SOP in 6%, and BA in 24.5%. The younger the patient and the more organ systems involved, the greater the probability of finding phagocytic impairment. Impaired chemotaxis correlated with recurrent aphthous stomatitis, infections associated with elevated IgE, and purulent upper respiratory tract infections. Impaired SOP and BA correlated with deep-seated abscesses, recurrent lymphadenitis, sepsis, and bone and joint and central nervous system infections. PPDs were identified in 5.7%, chronic granulomatous disease in 4.8%, neutrophil glucose-6-phosphate dehydrogenase deficiency in 0.3%, leukocyte adhesion deficiency type 1 in 0.4%, and myeloperoxidase deficiency in 0.2%. Phagocytic evaluation contributed to the diagnosis of hyperimmunoglobulin-E syndrome (n = 21) and Chediak-Higashi syndrome (n = 3). PPDs are identified in 5.7% of patients with recurrent pyogenic infections; in the remainder, phagocytic dysfunction may be related to deleterious effects of persistent infection, drug consumption, or disorders not yet established.
Tài liệu tham khảo
Geha RS, Notarangelo LD, Casanova JL, et al. International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee, primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. J Allergy Clin Immunol. 2007;120:776–94.
Dinauer MC. Disorders of neutrophil function: an overview. Meth Mol Biol. 2007;412:489–504.
Lakshman R, Finn A. Neutrophil disorders and their management. J Clin Pathol. 2001;54:7–19.
Delamaire M, Maugendre D, Moreno M, et al. Impaired leucocyte functions in diabetic patients. Diabet Med. 1997;14:29–34.
Alvarez I, Vazquez JJ, Fontan G, et al. Neutrophil chemotaxis and serum chemotactic activity in systemic lupus erythematosus. Scand J Rheumatol. 1978;7:69–74.
Gemmell CG. Antibiotics and neutrophil function: potential immunomodulating activities. J Antimicrob Chemother. 1993;31(Suppl B):23–33.
Hasçelik G, Sener B, Hasçelik Z. Effect of some anti-inflammatory drugs on human neutrophil chemotaxis. J Int Med Res. 1994;22:100–6.
Wagner JG, Roth RA. Neutrophil migration during endotoxemia. J Leukoc Biol. 1999;66:10–24.
Wolach B. Exercise and the immune system - Focusing on the effect of exercise on neutrophil functions. In: Zaslav KR, editor. Sports Medicine and Sports Injuries. Croatia: InTech Open Access Publisher; 2012 (in press).
Wolach B, Baehner RL, Boxer LA. Review: clinical and laboratory approach to the management of neutrophil dysfunction. Isr J Med Sci. 1982;18:897–916.
van den Berg JM, Kuijpers TW. Educational paper: defects in number and function of neutrophilic granulocytes causing primary immunodeficiency. Eur J Pediatr. 2011;170:1369–76.
Roos D, de Boer M, Kuribayashi F, et al. Mutations in the X-linked and autosomal recessive forms of chronic granulomatous disease. Blood. 1996;87:1663–81.
Etzioni A. Leukocyte adhesion deficiencies: molecular basis, clinical findings, and therapeutic options. Adv Exp Med Biol. 2007;601:51–60.
Ottonello L, Dapino P, Pastorino G, et al. Neutrophil dysfunction and increased susceptibility to infection. Eur J Clin Invest. 1995;25:687–92.
Carulli G, Azzara A, Minnucci S, et al. Neutrophil dysfunction in patients with recurrent infections. Eur J Clin Invest. 1996;26:944–5.
Bondestam M, Håkansson L, Foucard T, et al. Defects in polymorphonuclear neutrophil function and susceptibility to infection in children. Scand J Clin Lab Invest. 1986;46:685–94.
Brenneis H, Schmidt A, Blaas-Mautner P, et al. Chemotaxis of polymorphonuclear neutrophils (PMN) in patients suffering from recurrent infection. Eur J Clin Invest. 1993;23:693–8.
Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest Suppl. 1968;97:77–89.
Falk W, Goodwin Jr RH, Leonard EL. A 48-well micro-chemotaxis assembly for rapid and accurate measurement of leukocyte migration. J Immunol Methods. 1980;33:239–47.
Weisbart RH, Golde DW, Gasson JC. Biosynthetic human GM-CSF modulates the number and affinity of neutrophil f-Met-Leu-Phe receptors. J Immunol. 1986;137:3584–7.
Wolach B, Gavrieli R, de Boer M, et al. Chronic granulomatous disease in Israel: clinical, functional and molecular studies of 38 patients. Clin Immunol. 2008;129:103–14.
Clawson CC, Repine JE. Quantitation of maximal bactericidal capability in human neutrophils. J Lab Clin Med. 1976;88(2):316–27.
Vowells SJ, Sekhsaria S, Malech HL, et al. Flow cytometric analysis of the granulocyte respiratory burst: a comparison of fluorescent probes. J Immunol Methods. 1995;178:89–97.
Verhoeven AJ, Bolscher BG, Meerhof LJ, et al. Characterization of two monoclonal antibodies against cytochrome b558 of human neutrophils. Blood. 1989;73:1686–94.
Petersen TK, Bysted BV, Jensen AL. Determination of the adhesive capability of canine polymorphonuclear neutrophil granulocytes using a fluorometric microtiter plate cellular adhesion assay. Vet Immunol Immunopathol. 1999;68:283–91.
Kuijpers TW, Tool AT, van der Schoot CE, et al. Membrane surface antigen expression on neutrophils: a reappraisal of the use of surface markers of neutrophil activation. Blood. 1991;78:1105–11.
Standardization of procedures for the study of glucose-6-phosphate dehydrogenase: report of a WHO scientific group. World Health Organ Tech Rep Ser. 1967;366:1–53.
Grimbacher B, Holland SM, Gallin JI, et al. Hyper-IgE syndrome with recurrent infections: an autosomal dominant multisystem disorder. N Engl J Med. 1999;340:692–702.
Jeppson JD, Jaffe HS, Hill HR. Use of recombinant human interferon gamma to enhance neutrophil chemotactic responses in Job syndrome of hyperimmunoglobulinemia E and recurrent infections. J Pediatr. 1991;118:383–7.
Kaplan J, De Domenico I, Ward DM. Chediak–Higashi syndrome. Curr Opin Hematol. 2008;15:22–9.
Wolach B, Scharf Y, Gavrieli R, et al. Unusual late presentation of X-linked chronic granulomatous disease in an adult female with a somatic mosaic for a novel mutation in CYBB. Blood. 2005;105:61–6.
Wolach B, Ash S, Gavrieli R, et al. Acute lymphoblastic leukemia in a patient with chronic granulomatous disease and a novel mutation in CYBB: first report. Am J Hematol. 2005;80:50–4.
Wolach B, Eliakim A, Pomeranz A, et al. Cyclosporin treatment of hyperimmunoglobulin E syndrome. Lancet. 1996;347:67.
Slatter MA, Gennery AR. Clinical immunology review series: an approach to the patient with recurrent infections in childhood. Clin Exp Immunol. 2008;152:389–96.
Winkelstein JA, Marino MC, Johnston Jr RB, et al. Chronic granulomatous disease: report on a national registry of 368 patients. Medicine. 2000;79:155–69.
van den Berg JM, van Koppen E, Ahlin A, et al. Chronic granulomatous disease: the European experience. PLoS One. 2009;4:e5234.
Carr R. Neutrophil production and function in newborn infants. Br J Haematol. 2000;110:18–28.
Wolach B, Sonnenschein D, Gavrieli R, et al. Neonatal neutrophil inflammatory responses: parallel studies of light scattering, cell polarization, chemotaxis, superoxide release, and bactericidal activity. Am J Hematol. 1998;58:8–15.
Al-Nakeeb S, Thompson EN. Assessment of neutrophil chemotaxis and random migration in childhood: comparison between leading-front and lower surface count methods. Arch Dis Child. 1980;55:296–8.
Muniz-Junqueira MI, Peçanha LM, da Silva-Filho VL, et al. Novel microtechnique for assessment of postnatal maturation of the phagocytic function of neutrophils and monocytes. Clin Diagn Lab Immunol. 2003;10:1096–102.
Plebani A, Ugazio AG, Avanzini MA, et al. Serum IgG subclass concentrations in healthy subjects at different age: age normal percentile charts. Eur J Pediatr. 1989;149:164–7.
Israel Central Bureau of Statistics. Household expenditure survey 2007, Table 7.1: monthly income per household by type of locality. Available at: http://www.cbs.gov.il/publications09/1363/pdf/t07_1.pdf. Accessed 1 Sep 2011.
Newman PJ, Seligsohn U, Lyman S, et al. The molecular genetic basis of Glanzmann thrombasthenia in the Iraqi-Jewish and Arab populations in Israel. Proc Natl Acad Sci U S A. 1991;88:3160–4.
The Israeli National Genetic Database. Available at: http://www.goldenhelix.org/server/israeli/. Accessed 13 Nov 2011.
Behar DM, Yunusbayev B, Metspalu M, et al. The genome-wide structure of the Jewish people. Nature. 2010;466:238–42.
Giraldo E, Hinchado MD, Garcia JJ, et al. Influence of gender and oral contraceptives intake on innate and inflammatory response: role of neuroendocrine factors. Mol Cell Biochem. 2008;313:147–53.
Glasser L, Fiederlein RL. Functional differentiation of normal human neutrophils. Blood. 1987;69:937–44.
Golan H, Dalal I, Garty BZ, et al. The incidence of primary immunodeficiency syndromes in Israel. Isr Med Assoc J. 2002;4(11 Suppl):868–71.
Eades-Perner AM, Gathmann B, Knerr V, et al. ESID Registry Working Party: the European internet-based patient and research database for primary immunodeficiencies: results. 2004–06. Clin Exp Immunol. 2007;147:306–12.
Hartl D, Lehmann N, Hoffmann F, et al. Dysregulation of innate immune receptors on neutrophils in chronic granulomatous disease. J Allergy Clin Immunol. 2008;121(375–382):e9.
Iancovici-Kidon M, Sthoeger D, Abrahamov A, et al. A new exon 9 glucose-6-phosphate dehydrogenase mutation (G6PD "Rehovot") in a Jewish Ethiopian family with variable phenotypes. Blood Cells Mol Dis. 2000;26:567–71.
Wolach B, Ashkenazi M, Grossmann R, et al. Diurnal fluctuation of leukocyte G6PD activity: a possible explanation for the normal neutrophil bactericidal activity and the low incidence of pyogenic infections in patients with severe G6PD deficiency in Israel. Pediatr Res. 2004;55:807–13.
Simon AJ, Lev A, Wolach B, et al. The effect of gentamicin-induced read through on a novel premature termination codon of CD18 leukocyte adhesion deficiency patients. PLoS One. 2010;5:e13659.
Minegishi Y, Saito M, Tsuchiya S, et al. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature. 2007;448:1058–62.
Mazzone A, Girola S, Fossati G, et al. Job syndrome (hyper-IgE) and hypo-IgA: a rare association of immunodeficiencies [article in Italian]. Recenti Prog Med. 1996;87:71–4.